Correspondence to: Dr Hadi Manji The Mortimer Market Clinic, Capper Street, off Tottenham Court Road, London NW1, UK; hadi.manjibtinternet.com Since the onset of the AIDS pandemic in 1981, infection ...

Background The impact of body weight on disability progression rates among patients receiving ofatumumab was not evaluated yet. Methods Among patients from a multicentre prospective cohort, baseline ...

Objectives: The lack of agreement regarding assessment methods is responsible for the variability in the reported rate of occurrence of spatial neglect after stroke. The aim of this study was to ...

OBJECTIVES To clarify whether different causative events (trauma, stroke, intracranial surgery), time of intervention, and treatment mode influence outcome, patients with fixed and dilated pupils ...

a Department of Neurology, Chiba University School of Medicine, Chiba, Japan, b Department of Neurology, Dokkyo University School of Medicine, Tochigi, Japan Dr Satoshi Kuwabara, Department of ...

OBJECTIVES To calculate the expected number of life-years saved by surgical treatment of unruptured intracranial aneurysms at ages over 20 years. METHODS An actuarial risk analysis of the treatment of ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting the upper and lower motor neurons. A key clinical feature of ALS is the absence of accurate, early-stage ...

Dr Dorothy Wade is Consultant health psychologist at Royal Free London NHS Foundation Trust. She has a PhD in health psychology and healthcare evaluation from University College London, where she is ...

Department of Neurology, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester LE1 5WW, UK Correspondence to: Dr Y A Rajabally Department of Neurology, University Hospitals of ...

Dr Paul T Francis, Dementia Research Laboratory, Division of Biomolecular Sciences, Guy’s, King’s and St Thomas’ Schools of Biomedical Sciences, King’s College, St Thomas Street, London SE1 9RT, UK.

Objective Myelin oligodendrocyte glycoprotein-associated disorders (MOGADs) are a rare new neurological autoimmune disease with unclear pathogenesis. Since a linkage of the disease to the human ...

Correspondence to: Dr Patricia A McKinney Paediatric Epidemiology Group, Unit of Epidemiology and Health Services Research, University of Leeds, 32 Hyde Terrace, Leeds LS2 9LN, UK; ...